A Year In Review
Download this critical review for an in-depth look at the rapidly evolving cytokine therapy landscape. With over 3,000 therapies in development and a shift toward late-stage clinical focus, developers must navigate growing competition, regulatory scrutiny, and shifting investment trends.
Stay ahead with unmatched clinical and commercial insights from The Cytokine Landscape Review.
Download Now
Download the 2024 Cytokine Review for unparalleled information on the evolving cytokine landscape, from the rise of advanced modalities like bispecific antibodies and CAR-T cells to shifting clinical and regulatory trends. Gain insights into late-stage trial activity, recent approvals, and the changing investment climate shaping the future of cytokine therapies.
Report Contents
The Drug Landscape
A deep dive into the top therapeutic classes, disease indications and targets, as well as recent approvals and discontinuations.
The Trial Landscape
A breakdown of 2024’s cytokine clinical trials by phase progression, modality and target. Plus a list of early trial terminations.
The Commercial Landscape
Analysis of cytokine deal activity in 2024, including investment trends, and the evolving market dynamics shaping development.
The Future of the Cytokine Space
Upcoming trends, trials set to conclude in 2025, and strategic insights into the next wave of cytokine therapies set to shape the market.
Regulatory Updates
A review of 2024 regulatory activity, including drug approvals, IND submissions, breakthrough designations, and compliance trends affecting cytokine therapies.
You May Also Be Interested In...
Cytokine: 2024 Landscape Review
Bispecific: 2024 Landscape Review
ADC: 2024 Landscape Review
Strategic Insights for Biopharma Innovation Report
Cytokine TOI Digest Axatilimab Approval
H1 2024 Cytokine Landscape Review
Find Out More
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
